Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.

Item
http://www.wikidata.org/entity/Q36541873
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data.Management of Hypertension Using Olmesartan Alone or in CombinationSafety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiazide in clinical practice.Short Term Safety and Tolerability of a Fixed Dose Combination of Olmesartan, Amlodipine and HydrochlorothiazideCombined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval.Effectiveness of the fixed-dose combination of olmesartan/amlodipine/hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD.Triple-combination therapy in the treatment of hypertension: a review of the evidence.Primary Aldosteronism With Type 2 Diabetes Mellitus Requires More Antihypertensive Drugs for Blood Pressure Control: A Retrospective Observational Study.Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.Efficacy and tolerability of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide: a subgroup analysis of patients stratified by hypertension severity, age, sex, and obesity.Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
P2860

Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.

Item
http://www.wikidata.org/entity/Q36541873
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Olmesartan/amlodipine/hydrochl ...... parallel-group TRINITY study.
@ast
Olmesartan/amlodipine/hydrochl ...... parallel-group TRINITY study.
@en
type
label
Olmesartan/amlodipine/hydrochl ...... parallel-group TRINITY study.
@ast
Olmesartan/amlodipine/hydrochl ...... parallel-group TRINITY study.
@en
prefLabel
Olmesartan/amlodipine/hydrochl ...... parallel-group TRINITY study.
@ast
Olmesartan/amlodipine/hydrochl ...... parallel-group TRINITY study.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Olmesartan/amlodipine/hydrochl ...... parallel-group TRINITY study.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P921
P932